Last reviewed · How we verify
Acute ST segment elevation myocardial infarction
Approved treatments
- Plavix · Generic (originally Sanofi/BMS)
Irreversibly blocks the P2Y12 ADP receptor on platelets, inhibiting platelet aggregation and preventing arterial thrombosis.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Acute ST segment elevation myocardial infarction patent landscape — cliff calendar, originator estates, attackable patents
- Acute ST segment elevation myocardial infarction treatment landscape brief
- Acute ST segment elevation myocardial infarction treatment updates RSS
Frequently asked questions about Acute ST segment elevation myocardial infarction
What drugs treat Acute ST segment elevation myocardial infarction?
Tracked treatments include Plavix.
What is the treatment for Acute ST segment elevation myocardial infarction?
Standard treatment for Acute ST segment elevation myocardial infarction includes Plavix. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Acute ST segment elevation myocardial infarction patent cliff · Acute ST segment elevation myocardial infarction CI report
- Treatment: Plavix · Generic (originally Sanofi/BMS)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing